推荐文献 - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up
Level of Scientific Evidence Underlying the Current American College of Cardiology/American Heart Association Clinical Practice Guidelines
Randomized Comparison Between Radial and Femoral Large-Bore Access for Complex Percutaneous Coronary Intervention
Coronary Artery Calcium Is Associated with Left Ventricular Diastolic Function Independent of Myocardial Ischemia
Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization
Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association
Patient Characteristics Associated With Antianginal Medication Escalation and De-Escalation Following Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the OPEN CTO Registry
Home-Based Cardiac Rehabilitation: A Scientific Statement From the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology
Screening for Atrial Fibrillation With Electrocardiography US Preventive Services Task Force Recommendation Statement
Incidence, Predictors, and Outcomes of In-Hospital Percutaneous Coronary Intervention Following Coronary Artery Bypass Grafting

Original Research

July 15, 2021

JOURNAL：PLoS One.

Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association’s COVID-19 Cardiovascular Disease Registry

LB Daniels, JT Ren, K Kumar et al.

5203

Keywords: COVID-19; CVD patients; statin prevention; death

FULL TEXT PDF